Comments on some clinical implications of the release of adrenocorticotropin and vasopressin by interleukin-6 and other cytokines

Journal of Clinical Endocrinology and Metabolism

Volumn 79, Issue 4, 1994, Pages 932-933

  Moses, Arnold M ^a  

^a SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; CYTOKINE; INTERLEUKIN 6; VASOPRESSIN DERIVATIVE; ARGIPRESSIN; INTERLEUKIN 1; TUMOR NECROSIS FACTOR ALPHA;

CUSHING SYNDROME; HUMAN; METABOLISM; NOTE; PHYSIOLOGY; POLYURIA; SCHWARTZ BARTTER SYNDROME; CUSHING DISEASE; DIABETES INSIPIDUS; EDITORIAL; HORMONE RELEASE; HORMONE RESPONSE; INAPPROPRIATE VASOPRESSIN SECRETION; PLASMA OSMOLALITY; PRIORITY JOURNAL; WATER METABOLISM;

CORTICOTROPIN; CORTICOTROPIN-RELEASING HORMONE; CUSHING SYNDROME; CYTOKINES; HUMAN; INAPPROPRIATE ADH SYNDROME; INTERLEUKIN-6; POLYURIA; VASOPRESSINS;

EID: 0028519910     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jcem.79.4.7962299     Document Type: Article

References (23)

1. Bernardini R, Kamilaris TC, Calogero AE, et al. 1990 Interactions between tumor necrosis factor-alpha, hypothalamic corticotropin-releasing hormone, and adrenocorticotropin secretion in the rat. Endocrinology. 126:2876-2881.
2. Naito Y, Fukata J, Shindo K, et al. 1991 Effects of interleukins on plasma arginine vasopressin and oxytocin levels in consdous, freely moving rats. Biochem Biophys Res Commun. 174:1189-1195.
3. Kimura T, Yamamoto T, Ota K, et al. 1993 Central effects of interleukin-1 on blood pressure, thermogenesis, and the release of vasopressin, ACTH, and atrial natriuretic peptide. Ann NY Acad Sd. 689:330-345.
4. Brunetti L, Preziosi P, Ragazzoni E, et al. 1994 Effects of lipopoly-saccharide on hypothalamic-pituitary-adrenal axis in vitro. Life Sd. 54:165-171.
5. Mastorakos G, Chrousos GP, Weber JS. 1993 Recombinant interleukin-6 activates the hypothalamic-pituitary-adrenal axis in humans. J Clin Endocrinol Metab. 77:1690-1694.
6. Mastorakos G, Weber JS, Magiakou MA, et al. Hypothalamic-pituitary-adrenal axis activation and stimulation of systemic vasopressin secretion by recombinant interleukin 6 in humans: potential implications for the syndrome of inappropriate vasopressin secretion. J Clin Endocrinol Metab. In press.
7. Reichlin S. 1993 Neuroendocrine-immune interactions. N Engl J Med. 329:1246-1253.
8. Wilder TS, Drake TGH. 1929 Metabolism of chloride and total fixed base in pneumonia and the relation to salt and water retension. J Clin Invest. 7:353-360.
9. Winkler AW, Crankshaw OF. 1938 Chloride depletion in conditions other than Addison's disease. J Clin Invest. 17:1-6.
10. Shalhoub RJ, Antoniou LD. 1969 Die mechanism of hyponatremia in pulmonary tuberculosis. Ann Intern Med. 70:943-962.
11. Rosenow III EC, Segar WE, Zehr JE. 1972 Inappropriate antidiuretic hormone secretion in pneumonia. Mayo Clin Proc. 47:169-174.
12. Petty BG, Smith CR. 1977 The syndrome of inappropriate secretion of antidiuretic hormone associated with anaerobic thoracic empyema. Am Rev Respir Dis. 115:685-688.
13. Siersback-Nielsen K, Hansen JM, Reisby N, et al. 1970 Increased urinary excretion of antidiuretic material in encephalitis. Acta Neurol Scand. 46:648-652.
14. Bauer J, Herrmann F. 1991 Interleukin-6 in clinical medicine. Ann Hematol. 62:203-210.
15. Kimble RB, Vannice JL, Bloedow DC, et al. 1994 Interleukin-1 receptor antagonist decreases bone loss and bone resorption in ovariectomized rats. J Clin Invest. 93:1959-1967.
16. Moses AM. 1989 Osmotic thresholds for AVP release with the use of plasma and urine AVP and free water clearance. Am J Physiol. 256:R892-R897.
17. Moses AM, Streeten DHP. 1994 Disorders of the neurohypophysis. In: Isselbacher KJ, et al, eds. Harrison's principles of internal medicine, 13th ed. New York: McGraw-Hill; 1921-1930.
18. Moses AM, Clayton B. 1993 Impairment of osmotically stimulated AVP release in patients with primary polydipsia. Am J Physiol. 265:R1247-R1252.
19. Moses AM, Clayton B, Hochhauser L. 1992 Use of Tl-weighted MR imaging to differentiate between primary polydipsia and central diabetes insipidus. Am J Neuroradiol. 13:1273-1277.
20. Moses AM, Scheinman SJ. 1993 Hereditary vasopressin resistance in man and mouse. Ann NY Acad Sd. 689:233-249.
21. Aarskog D, Blizzard RM, Migeon CJ. 1965 Response to metho-pyrapone (Su-4885) and pyrogen test in idiopathic hypopituitary dwarfism. J Clin Endocrinol Metab. 25:439-444.
22. Kohler PO, O'Malley BW, Rayford PL, et al. 1967 Effect of pyrogen on blood levels of pituitary trophic hormones: observations of the usefulness of the growth hormone response in the detection of pituitary disease. J Clin Endocrinol Metab. 27:219-226.
23. Miller M, Moses AM. 1968 Effect of temperature and dexametha-sone on the plasma 17-hydroxycorticoid and growth hormone responses to pyrogen. J Clin Endocrinol Metab. 28:1056-1062